Comparison of PD-L1 immunohistochemistry assays and response to PD-1/L1 inhibitors in advanced non-small-cell lung cancer in clinical practice.
Liza C VillaruzKaterina Ancevski HunterBrenda F KurlandShira AbberbockCameron HerbstSanja DacicPublished in: Histopathology (2018)
The SP263 and 22C3 LDTs demonstrated good analytical concordance, and correlation with response to PD-1/L1 inhibitors.